StockData
REGENXBIO Inc. logo

REGENXBIO Inc. (RGNX) stock

RGNXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.26+0.02 (+0.28%)

Close on Nov 18, 2026Market cap $479.26MP/E –Yield –

Regenxbio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Regenxbio's market cap was $458.77M on Nov 11, 2026, against $677.79M a year earlier. Over the last 5 years it ranged from $325.54M to $1.42B, with a median of $677.79M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$458.77M-37.1%
2025Dec 31, 2025$728.91M+90.4%
2024Dec 31, 2024$382.90M-51.5%
2023Dec 29, 2023$789.64M-19.6%
2022Dec 30, 2022$981.86M-29.8%
2021Dec 31, 2021$1.40B-17.6%
2020Dec 31, 2020$1.70B+12.4%
2019Dec 31, 2019$1.51B+0.8%
2018Dec 31, 2018$1.50B+44.8%
2017Dec 29, 2017$1.03B+110.6%
2016Dec 30, 2016$491.11M+12.5%
2015Dec 31, 2015$436.68M–

More Regenxbio figures

See a number that looks wrong?